Answers are grounded in this paper and cite their sources.
Observational analysis reveals India's rise in clinical trials, yet highlights concerns over regulation and ethics.
India’s vast patient population and growing healthcare infrastructure has seen it overtake the US as a go-to for clinical trials. But unethical practices worry doctors as the sector expands, writes Neha Bhatt
No takes yet. Share an insight, caveat, or question.
Neha Bhatt (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: